关注
Hareesh Nair
Hareesh Nair
Associate Professor/Research
在 uthscsa.edu 的电子邮件经过验证
标题
引用次数
引用次数
年份
RETRACTED: Design of curcumin-loaded PLGA nanoparticles formulation with enhanced cellular uptake, and increased bioactivity in vitro and superior bioavailability in vivo
P Anand, HB Nair, B Sung, AB Kunnumakkara, VR Yadav, RR Tekmal, ...
Biochemical pharmacology 79 (3), 330-338, 2010
7862010
RETRACTED: Thymoquinone poly (lactide-co-glycolide) nanoparticles exhibit enhanced anti-proliferative, anti-inflammatory, and chemosensitization potential
J Ravindran, HB Nair, B Sung, S Prasad, RR Tekmal, BB Aggarwal
Biochemical pharmacology 79 (11), 1640-1647, 2010
1942010
Induction of aromatase expression in cervical carcinomas: effects of endogenous estrogen on cervical cancer cell proliferation
HB Nair, R Luthra, N Kirma, YG Liu, L Flowers, D Evans, RR Tekmal
Cancer research 65 (23), 11164-11173, 2005
1232005
Elevated Expression of the Oncogene c-fms and Its Ligand, the Macrophage Colony-Stimulating Factor-1, in Cervical Cancer and the Role of Transforming Growth Factor-β1 …
N Kirma, LS Hammes, YG Liu, HB Nair, PT Valente, S Kumar, LC Flowers, ...
Cancer research 67 (5), 1918-1926, 2007
852007
Modeling the early endometriotic lesion: mesothelium-endometrial cell co-culture increases endometrial invasion and alters mesothelial and endometrial gene transcription
AS Nair, HB Nair, RS Lucidi, AJ Kirchner, RS Schenken, RR Tekmal, ...
Fertility and sterility 90 (4), 1487-1495, 2008
732008
Overexpression of the Colony-Stimulating Factor (CSF-1) and/or Its Receptor c-fms in Mammary Glands of Transgenic Mice Results in Hyperplasia and Tumor …
N Kirma, R Luthra, J Jones, YG Liu, HB Nair, U Mandava, RR Tekmal
Cancer research 64 (12), 4162-4170, 2004
702004
Targeting LIF/LIFR signaling in cancer
S Viswanadhapalli, KV Dileep, KYJ Zhang, HB Nair, RK Vadlamudi
Genes & Diseases 9 (4), 973-980, 2022
682022
EC359: a first-in-class small-molecule inhibitor for targeting oncogenic LIFR signaling in triple-negative breast cancer
S Viswanadhapalli, Y Luo, GR Sareddy, B Santhamma, M Zhou, M Li, ...
Molecular cancer therapeutics 18 (8), 1341-1354, 2019
662019
Modeling ductal carcinoma in situ: a HER2–Notch3 collaboration enables luminal filling
CR Pradeep, WJ Köstler, M Lauriola, RZ Granit, F Zhang, J Jacob-Hirsch, ...
Oncogene 31 (7), 907-917, 2012
642012
Progesterone receptor isoforms, agonists and antagonists differentially reprogram estrogen signaling
H Singhal, ME Greene, AL Zarnke, M Laine, R Al Abosy, YF Chang, ...
Oncotarget 9 (4), 4282, 2018
632018
Induction of endometrial epithelial cell invasion and c-fms expression by transforming growth factor beta
Y Liu, RR Tekmal, PA Binkley, HB Nair, RS Schenken, NB Kirma
Molecular human reproduction 15 (10), 665-673, 2009
592009
Estrogen receptor alpha is required for mammary development and the induction of mammary hyperplasia and epigenetic alterations in the aromatase transgenic mice
RR Tekmal, YG Liu, HB Nair, J Jones, RP Perla, DB Lubahn, KS Korach, ...
The Journal of steroid biochemistry and molecular biology 95 (1-5), 9-15, 2005
482005
Modulation of in Situ Estrogen Synthesis by Proline-, Glutamic Acid-, and Leucine-Rich Protein-1: Potential Estrogen Receptor Autocrine Signaling Loop in Breast …
R Rajhans, HB Nair, SS Nair, V Cortez, K Ikuko, NB Kirma, D Zhou, ...
Molecular endocrinology 22 (3), 649-664, 2008
372008
Increased expression of macrophage colony–stimulating factor and its receptor in patients with endometriosis
NM Budrys, HB Nair, YG Liu, NB Kirma, PA Binkley, S Kumar, ...
Fertility and sterility 97 (5), 1129-1135. e1, 2012
352012
Hyaluronic acid-bound letrozole nanoparticles restore sensitivity to letrozole-resistant xenograft tumors in mice
HB Nair, S Huffman, P Veerapaneni, NB Kirma, P Binkley, RP Perla, ...
Journal of nanoscience and nanotechnology 11 (5), 3789-3799, 2011
312011
Estrogen receptor-β activation in combination with letrozole blocks the growth of breast cancer tumors resistant to letrozole therapy
HB Nair, NB Kirma, M Ganapathy, RK Vadlamudi, RR Tekmal
Steroids 76 (8), 792-796, 2011
292011
Utilizing cell line-derived organoids to evaluate the efficacy of a novel LIFR-inhibitor, EC359 in targeting pancreatic tumor stroma
BR Hall, A Cannon, C Thompson, B Santhamma, A Chavez-Riveros, ...
Genes & cancer 10 (1-2), 1, 2019
262019
BU-32: a novel proteasome inhibitor for breast cancer
JK Agyin, B Santhamma, HB Nair, SS Roy, RR Tekmal
Breast Cancer Research 11, 1-13, 2009
262009
Growth inhibitory efficacy of Cornus officinalis in a cell culture model for triple‑negative breast cancer
NT Telang, HB Nair, GYC Wong
Oncology letters 17 (6), 5261-5266, 2019
252019
Gossypin as a novel selective dual inhibitor of V-RAF murine sarcoma viral oncogene homolog B1 and cyclin-dependent kinase 4 for melanoma
S Bhaskaran, KV Dileep, SS Deepa, C Sadasivan, M Klausner, ...
Molecular cancer therapeutics 12 (4), 361-372, 2013
252013
系统目前无法执行此操作,请稍后再试。
文章 1–20